This content is machine translated DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline Stroke prevention for atrial fibrillation 2025 Atrial fibrillation is the most important treatable risk factor for ischemic strokes in 2025 – and at the same time an area where precision makes all the difference. The major...…
View Post 6 min This content is machine translated From early intervention to individualization The new guidelines at a glance At the ESC Congress 2025, several guidelines and a consensus document were published or revised, which together will have a noticeable impact on everyday cardiology: a focused update on lipid...…
View Post 5 min This content is machine translated Arterial hypertension: ESC guideline 2024 in focus New category “elevated blood pressure” – what are the therapeutic implications? According to the guideline of the European Society of Cardiology (ESC), which was updated last year, blood pressure values of 120-139/70-89 mmHg are considered “raised blood pressure”. Drug therapy is...…
View Post 4 min This content is machine translated Atrial fibrillation What’s new with the “pace-and-ablate” strategy? Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with increased morbidity and mortality. The guideline of the European Society for Cardiology (ESC), which was updated last...…
View Post 4 min This content is machine translated CHD: Management after revascularization Individualization of antithrombotic therapy Coronary heart disease (CHD) is one of the most common heart diseases worldwide and is currently grouped into two syndromes: acute coronary syndrome (ACS) and chronic coronary syndrome (CCS). Following...…
View Post 5 min This content is machine translated Acute heart failure Diuretic therapy for decongestion – what are the “unmet needs”? Acute heart failure is a life-threatening condition. According to current guideline recommendations of the European Society of Cardiology (ESC), drug therapy after acute decompensation should be implemented while the patient...…
View Post 7 min This content is machine translated Updated guidelines for hypertension Elevated blood pressure as a new category In October, the European Society of Cardiology (ESC) published its 2024 guidelines for the treatment of high blood pressure and hypertension. At the swissESCupdate, Dr. Lucas Lauder from the University…
View Post 8 min This content is machine translated Heart failure: ESC guideline update 2023 Therapy-relevant new evidence on the entire EF spectrum The update of the ESC guideline on the treatment of heart failure includedthe results of large randomized studies that were not published until after the guideline was published in 2021.…
View Post 4 min This content is machine translated Type 2 diabetes ESC recommendations for reducing cardiovascular risk Patients with type 2 diabetes have a greatly increased risk of developing cardiovascular disease compared to healthy people in the same age group. The current guidelines published in the European…
View Post 4 min This content is machine translated Heart failure: ESC guideline update 2023 Treatment of HFmrEF – what’s new? The European Society of Cardiology (ESC) recently updated its guidelines. Consequently, based on the EMPEROR-Preserved and DELIVER trials, the use of SGLT-2 inhibitors is now recommended for all stages of…
View Post 6 min This content is machine translated Cardiac arrhythmias Atrial fibrillation – what do current guidelines say? Atrial fibrillation is the most common sustained cardiac arrhythmia and is associated with significantly increased mortality and morbidity. Therefore, timely diagnostic and therapeutic measures are required. The current ESC guidelines…
